To date, the glycoprotein endoglin and its receptor complex, formed between TGF and TGF R-2, have been studied in tumor angiogenesis. The purpose of this study is to investigate the expression profile of endoglin and its receptor complex in human atherosclerotic lesions, and compare it to that in non-atherosclerotic tissues. Twenty-six atherosclerotic lesions and twenty-six non-atherosclerotic aortic tissues were collected from thirty-six autopsy cases. Indirect immunohistochemical staining was performed to detect the presence of endoglin, TGF -1, and TGF R-2 proteins in aortic tissues. 
Introduction
Endoglin (CD105), a cell membrane glycoprotein, is a homodimeric transmembrane receptor for transforming growth factor (TGF) -1 and TGF 3, and forms a TGF beta receptor complex on endothelial cells 1) . Endoglin can bind TGF -1 and TGF -3 with high affinity and appears to do so only in the presence of TGF R-2 2, 3) . So far, the role of endoglin in angiogenesis has been studied primarily in tumor endothelial cells of various organs [4] [5] [6] [7] [8] . A marked increase in the expression of endoglin has been demonstrated on the surface of vascular endothelial cells 9) . A recent study which investigated patients with coronary artery disease suggested that endoglin may be important in the pathogenesis of atherosclerotic disease 10) . There have been some reports that endoglin is expressed in atherosclerotic plaques, such as in smooth muscle cells 11, 12) or in calcification-associated atherosclerotic lesions 13) . However, to the best of our knowledge, the expression profiles of endoglin in association with TGF and its receptor, which compose a functional receptor complex, have not been studied in human atherosclerotic plaques.
TGF has marked effects on cell proliferation, differentiation, adhesion, migration, and extracellular matrix (ECM) production, as well as other activities 14) . The role of TGF in the pathogenesis of atherosclerosis is being recognized. Its regulatory function on the vessel wall is directed at the vascular SMCs, endothelial cells and ECM. TGF -1 plays an important role as an endogenous growth regulatory factor produced by the neointimal SMCs themselves during progressive neointimal thickening after balloon angioplasty in an animal model 15) .The purpose of this study is to examine the expression of endoglin with its receptor complex in atherosclerotic lesions using immunohistochemistry and to evaluate its role in atherogenesis.
In fact, recent studies indicate that angiogenesis may be involved in the progress of atherosclerosis, having an important role in atherogenesis. Inoue et al. 16) observed the expression of VEGF and its two receptors, flt-1 and Flk-1, in human coronary atherosclerosis. Furthermore, a study using DNA array technology showed up-regulation of the Flk-1 gene in human atherosclerotic plaques 17) . In the present study, we detected the expression of endoglin (CD105) with the TGF receptor complex system, as well as VEG-FR-2 (Flk-1), angiogenesis-related factors in human aortic atherosclerotic lesions, by immunohistochemistry. A comparison was then made with non-atherosclerotic aortic tissue samples obtained from various autopsy cases (infant to elderly adults).
Materials and Methods

Specimens
A total of 52 specimens (26 atherosclerotic, 26 non-atherosclerotic) were obtained from 36 autopsy cases at the Department of Pathology, Saga University Hospital, as previously described 18) . Each aorta was opened longitudinally, and then the appropriate lesions were dissected and fixed in 10% buffered formalin. One or more lesion samples were studied from each case. In seven autopsy cases, both the atherosclerotic plaques and the non-atherosclerotic aortic tissues were obtained from the same aorta. Aortic tissues were embedded in paraffin and stained with hematoxylin and eosin (H.E.). Serial sections 4 m thick were used for immunohistochemical stainings. The atherosclerotic lesions were classified as type to type according to Stay et al. (American Heart Association, AHA) 19, 20) . Types to were classified as early lesions, and types to , as advanced lesions.
Immunohistochemistry
Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded sections using the indirect immunoperoxidase method. Sections were deparaffinized in xylene and hydrolyzed with 100%, 90%, 80%, and 70% ethanol, and then washed with PBS. Endogenous peroxidase was blocked with 0.3% H2O2 in methanol for 15 minutes. Antigen retrieval on paraffin sections was performed by heating in a 10 mM citrate buffer solution (pH 6.0) or ethylene-diaminetetraacetic acid (EDTA, pH 8.0) in a microwave for 5-7 minutes, and then cooling at room temperature for 30 min. After rinsing with phosphate-buffered saline (PBS), sections were incubated with each antibody at 4 overnight or at room-temperature for 1 hour. Identification of the distribution of the primary antibody was achieved by subsequent application of a biotinylated primary antibody and streptavidin peroxidase. The peroxidase reaction was visualized using a solution of 3,3´-diaminobenzidine tetrachloride (DAB)/H2O2. The sections were counterstained with hematoxylin, dehydrated, and then mounted. The antibodies used and the method of antigen retrieval are listed in Table 1 .
Immunostaining Evaluation
Immunostaining scores were calculated as the total number of positive cells divided by the total number of the cells at 400 hyperfield (HPF), in the hot spot of each lesion. A score of 0 means the number of positive cells is less than 5% of the total number of cells, a score of 1 means positive cells comprise 6-20% of all cells, a score of 2, 21-50%, and a score of 3, 51-100%. The average immunostaining score of each group was calculated and compared.
Statistical Analysis
The Statistical significance of the relation between immunostaining score and degree of atherosclerosis was analyzed using Student's t -test and Fisher's exact probability test. The Correlation among CD105, TGF -1 and TGF R-2 expression was examined using a multiple correspondence analysis. A p-value of 0.05 was considered significant. 
Results
Non-Atherosclerotic Aortas and Endoglin, TGF -1 and TGF R-2 Expression
Non-atherosclerotic tissues were obtained from patients in every decade of life, from a 23-week old aborted fetus to a 75-year old female with gastric cancer (see Table 2 ). Primary causes of death varied from infection, allergy, and malignant disorder, to suicide. No foamy macrophages were detected by H.E. staining and CD68 immunostaining.
Endoglin was only expressed in 2 (7.69%) of 26 cases in the non-atherosclerotic aortic sections, and most of the aortas showed a negative reaction. In the two endoglin-positive cases, endoglin expression was only observed in the focal areas of the endothelium and intima. Neither the status of the diseases nor aging itself had an effect on endoglin expression. TGF -1, however, was detected in half of the non-atherosclerotic sections. Most of the signals were observed in the endothelial cells. The average immunostaining score of TGF -1 for all non-atherosclerotic aortas was 0.81. TGF R-2 was expressed in 8 of 26 (30.77%) sections of the non-atherosclerotic aortas, and the average score was 0.38. There was only one case in which all three proteins, endoglin, TGF -1, and TGF R-2, were expressed (case 22 in the non-atherosclerotic group), and there was no correlation among the expression of endoglin, TGF -1 and TGF R-2 in the non-atherosclerotic aorta (p 0.05). All of the immunostaining results are listed in Table 2 , and representative immunostaining patterns are shown in Fig. 1 .
Atherosclerotic Aorta and Endoglin Expression
Atherosclerotic lesions were classified as Type to Type according to Stay et al. 19, 20) . Foamy macrophages were observed in all lesions of atherosclerotic plaques detected by CD68 immunostaining ( Table 2) . Eleven atherosclerotic lesions were collected from the same individuals (from seven cases) with the non-atherosclerotic tissues. Causes of death proved not to affect the atherosclerotic grade. For example, the nonatherosclerotic lesion of No. 23 and atherosclerotic lesions of No. 2 (Grade ), No. 16 (Grade ) and No. 26 (Grade ) were collected from the same 73-year old female who suffered from Adult T-cell lymphoma, the expression profiles, however, were lesion-specific.
In the atherosclerotic aortas, endoglin was expressed in 69% of the sections. The average immunostaining score was significantly higher than that of the non-atherosclerotic group (Fig. 2) . The signals for endoglin were observed in SMC and macrophages at the shoulders of the plaques and the fibrous caps or in aortic endothelial cells in advanced lesions. In early aortic lesions, the expression was observed in the cytoplasm of macrophages or endothelial cells, and the signals were weak. The average immunostaining scores of endoglin were higher in advanced lesions than early lesions (Fig. 3) . The immunostaining results are listed in Table 2 , and representative immunostaining patterns are shown in Fig. 1 .
TGF -1 and TGF R-2 Expression in Atherosclerotic Aorta
In atherosclerotic aortas, TGF -1 was expressed in 96.15% of the specimens and TGF R-2 was expressed in 76.92%. Most of the signals for TGF -1 and TGF R-2 were observed in the matrices of the intima, smooth muscle cells, and macrophages, as well as in endothelial cells (Fig. 1, C3 and C4 ). The average immunostaining scores of TGF -1 and TGF R-2 were higher in the atherosclerotic group than in nonatherosclerotic aortas (Fig. 2) . The immunostaining score of TGF R-2 was significantly higher in advanced lesions than in early lesions of atherosclerotic plaques (Fig. 3) . At the same time, the immunostaining of TGF -1 became stronger with the severity of the atherosclerotic type (p 0.05).
In the atherosclerotic group, there were 16 (61.54%) plaques that simultaneously expressed all three proteins, endoglin, TGF -1 and TGF R-2, and the expression showed a significant correlation in the correspondence analysis (p 0.001). There were some cases where all three proteins were not expressed simultaneously in the atherosclerotic lesions but were observed in the early lesions, so it was thought that the complex had not formed yet in the early lesions.
Detection of another Atherosclerotic Marker
In the present study, we also detected the expression of Flk-1, which is thought to be involved in atherosclerosis by mediating the signals for endothelial proliferation and vascular permeability from VEGF. Signals of various intensities were observed in 18 of 26 (69.2%) lesions of the atherosclerotic group, while only mild positive signals were observed in 3 of 26 sections (11.5%) of the non-atherosclerotic group. The immunostaining score of Flk-1 was significantly higher in the atherosclerotic lesions than in the non-atherosclerotic sections (Fig. 2) . Expression of Flk-1 was mainly observed in the cytoplasm of macrophages and aortic endothelial cells of atherosclerotic lesions (Fig. is not shown) .
Discussion
This is the first report of the simultaneous ex- Atherosclerotic group  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26   66F  73F  53F  53F  69M  75F  62M  62M  53F  33M  59M  60M  62M  38M  33M  73F  33M  59M  33F  33F  33F  33F  69M  69M  69M 0  0  0  1  1  0  3  0  1  1  1  0  2  1  0  2  1  2  3  2  1  1  3  3   2  3  1  1  1  3  2  0  3  2  3  1  2  2  3  3  2  3  3  3  3  2  2  1  3  3   0  0  0  0  0  3  1  1  1  2  2  1  3  3  3  3  1  3  2  2  1  0  2  1  3  3   1  1  1  3  1  2  2  2  2  2  3  3  3  3  3  3  1  3  2  2  1  1  3  2  3  3   0  0  2  1  1  3  1  3  1  0  3  3  1  2  3  2  0  2 Only weak signals are noted in endothelial cells for TGF -1 (A3), and CD105 (A2), TGF R-2 (A4) and CD68 (A5) are negative. The atherosclerotic Type specimen is from a 62-year-old male (case 13 of the As group). An extracellular accumulation of lipid is observed in the musculoelastic layers of the thickened intima by HE staining (B1). Endothelial cells and macrophages in the intima are positive for CD105 (B2) and TGF -1 (B3). TGF R-2 is strongly positive in endothelial cells, SMCs and macrophages (B4). Many CD68-positive cells are seen in the intima, but not in the media (B5). The atherosclerotic type lesion is from the ruptured atheroma of a 73-year-old female (case 26 of the As group). The core of the atheroma was washed out and disappeared and the margin of the fibrous capsule barely remained (C1). Immunostaining was strongly positive for CD105 (C2), TGF -1 (C3), TGF R-2 (C4) and CD68 (C5). Note the matrices are strongly positive for TGF -1 and TGF R-2. pression of endoglin, TGF -1, and TGF R-2 in the human atherosclerotic aorta. The expression of endoglin was observed in endothelial cells, activated macrophages, and smooth muscle cells in atherosclerotic plaques, a pattern consistent with a previous report 11) . Endoglin can bind TGF -1 and TGF -3 with high affinity 1) ; however, endoglin alone does not bind TGF and requires the presence of TGF R-2 2, 3) . Thus, endoglin together with TGF -1 and TGF R-2 form the TGF receptor complex. Li et al. 10) reported that in patients with coronary artery disease, serum levels of CD105 and TGF -1 were diminished, but the level of CD105/TGF -1 complex was elevated. In the present study, the expression of CD105/TGF -1/ TGF R-2 was detected immunohistologically in serial sections of the atherosclerotic aortas, which suggests the complex is deposited at these sites, and thus, may result in a decrease of circulating levels of active CD105 or TGF . Conley et al. 11) observed that endoglin expression in cultured human aortic SMCs was up-regulated in response to TGF -1, and thus concluded that the presence of TGF -1 in the atherosclerotic plaque might be responsible for the increased endoglin expression. In the present study, we observed a correlation of CD105/TGF -1/TGF R-2 expression in the atherosclerotic lesions but not the non-atherosclerotic aortas; furthermore the proteins were mainly observed in the advanced lesions, which indicates that endoglin or its receptor complex may participate in atherogenesis and the development of atherosclerosis. However, at present we do not know what caused the increased levels of endoglin. Thus, further study is necessary to clarify the causal factor for the increase in endoglin and the mechanism of interaction between endoglin and the TGF complex.
The role of TGF -1 in the vessel wall is complicated. TGF -1 is a potentially negative modulator in a number of cell types, e.g., it inhibits the proliferation of vascular smooth muscle cells (VSMCS) 21) . The role of TGF -1 in atherosclerosis is also controversial. Grainger et al. thought TGF -1 is anti-atherogenic 22, 23) , whereas others provided evidence that it is atherogenic, because elevated TGF -1 levels were found in vessel wall lesions 24, 25) and the localization of TGF -1 correlates with areas of intimal thickening where an increase in the amount of matrix was observed (areas of ECM production) [25] [26] [27] [28] . In the present study, signals for TGF -1 were usually observed in the extracellular matrix of the intima and occasionally in macrophages and endothelial cells. We observed an increased expression of TGF -1 in atherosclerotic lesions and moreover, an especially strong over-expression and higher expression rate in the advanced lesions, indicating that TGF -1 participates in the formation of early lesions and the progression to advanced lesions.
Neovascularization is now recognized in atherosclerotic plaques. However, It is not clear whether the neovascularization is pro-atherosclerotic or anti-atherosclerotic. Vascular endothelial growth factor (VEGF) has been studied in cultured cells and in atherosclerotic plaques for its role as a promoter of neovascularization. VEGF has two receptors, Flt-1 (VEG-FR-1) and Flk-1 (VEGFR-2). Flk-1 is known as the major regulator of endothelial proliferation and vascular permeability in response to VEGF 29) . In fact, upregulation of the Flk-1 gene was detected in human atherosclerotic plaques using DNA array technology 17) . In the present study, we clearly observed the expression of Flk-1 and endoglin in atherosclerotic lesions of types through to , whereas non-atherosclerotic le- 16) , as they stated that VEGF could be one of the growth factors involved in the development of intraplaque microvessels in human coronary arteries. Because the major signal from VEGF for endothelial proliferation and vascular permeability occurs through Flk-1, the up-regulated expression of Flk-1 may cause vascular endothelial proliferation or neovascularization.
In conclusion, we observed an increased expression of the angiogenesis-related genes, glycoprotein endoglin, TGF -1, TGF R-2, and Flk-1, in the human atherosclerotic aorta. Also, we observed a correlation in the expression of endoglin/TGF -1/TGF R-2 in atherosclerotic aortas. It is evident that atherosclerotic lesions express these genes. However, further study is necessary to clarify whether the genes are causative or a result of the atherogenesis.
